Component: (Network and Table) | |
---|---|
Network | 00500 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (http://www.universalamerican.com/role/StatementConsolidatedStatementsOfCashFlows) |
Table | (Implied) |
Reporting Entity [Axis] | 0001514128 (http://www.sec.gov/CIK) |
CONSOLIDATED STATEMENTS OF CASH FLOWS | Period [Axis] | ||
---|---|---|---|
2016-01-01 - 2016-12-31 | 2015-01-01 - 2015-12-31 | 2014-01-01 - 2014-12-31 | |
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
Operating activities: | |||
Net income (loss) | 55,376,000 | (163,969,000) | (29,467,000) |
Income (loss) from discontinued operations | (61,666,000) | 160,273,000 | 2,859,000 |
Loss from continuing operations | (6,290,000) | (3,696,000) | (26,608,000) |
Adjustments to reconcile net income loss to cash (used for) provided by operating activities: | |||
Deferred income taxes | ( | ( | |
Net realized gains on investments | ( | ( | ( |
Realized (gain) loss on sale of business | ( | ||
Amortization of intangible assets | 933,000 | 2,110,000 | 2,600,000 |
Amortization of debt issuance costs | |||
Amortization of debt discount on convertible notes | |||
Net amortization of bond premium | |||
Depreciation expense | |||
Stock based compensation expense | |||
Changes in operating assets and liabilities: | |||
Policy and contract claims | ( | ( | ( |
Reinsurance recoverables | ( | ||
Due and unpaid/advance premiums | ( | ( | |
Net amounts payable to discontinued operations | |||
Income taxes receivable | ( | ||
Other healthcare receivables | ( | ||
Other, net | ( | ( | |
Cash provided by operating activities of continuing operations | |||
Cash (used for) provided by operating activities of discontinued operations | ( | ( | |
Cash provided by (used for) operating activities | ( | ||
Investing activities: | |||
Proceeds from sale, maturity, call, paydown or redemption of fixed maturity investments | |||
Cost of fixed maturity investments acquired | ( | ( | ( |
Change in short-term investments | ( | ||
Proceeds of sale of cost method investments | |||
Sale of business, net of cash sold | |||
Purchase of fixed assets | ( | ( | ( |
Other investing activities | ( | ( | |
Cash (used for) provided by investing activities of continuing operations | ( | ||
Cash provided by investing activities of discontinued operations | |||
Cash provided by investing activities | |||
Financing activities: | |||
Net proceeds from issuance of common and preferred stock, net of tax effect | ( | ( | |
Share buyback/cancellation | ( | ( | |
Dividends paid to stockholders | ( | ( | |
Principal payment on loan payable | ( | ||
Proceeds from the issuance of convertible senior notes | |||
Payment of issue costs - convertible senior notes | ( | ||
Distributions from discontinued operations | ( | ||
Cash provided by (used for) financing activities of continuing operations | ( | ( | |
Cash used for financing activities of discontinued operations | ( | ( | |
Cash used for financing activities | ( | ( | ( |
Net increase (decrease) in cash and cash equivalents | ( | ||
Less: decrease (increase) in cash and cash equivalents from discontinued operations | ( | ||
Net increase (decrease) in cash and cash equivalents from continuing operations | ( | ||
Cash and cash equivalents of continuing operations at beginning of period | 70,546,000 | ||
Cash and cash equivalents of continuing operations at end of period | 104,462,000 | 70,546,000 | 94,376,000 |
Supplemental Cash Flow Information: | |||
Interest payments | |||
Cash paid (received) for income taxes | ( | ( |